$32.75
+0.15 (+0.46%)
Performance
1D
—
1W
—
1M
—
3M
-6.96%
6M
+22.06%
1Y
+81.84%
YTD
-3.25%
Open$32.51
Previous Close$32.60
Day High$33.51
Day Low$32.17
52W High$39.28
52W Low$13.45
Volume—
Avg Volume888.3K
Market Cap2.90B
P/E Ratio—
EPS$-1.30
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$34.24
Below
SMA 200
$27.52
Above
RSI (14)
49.6
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
25 analysts
Price Target
+259.3% upside
Current
$32.75
$32.75
Target
$117.67
$117.67
$81.99
$117.67 avg
$158.58
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 223.27M | 137.36M | 384.15M |
| Net Income | -116,065,057 | -64,266,366 | -80,984,777 |
| Profit Margin | -52.0% | -49.4% | -21.1% |
| EBITDA | -159,875,122 | -93,442,454 | -85,173,040 |
| Free Cash Flow | — | — | -100,075,430 |
| Rev Growth | +62.5% | +62.5% | -7.8% |
| Debt/Equity | — | — | 0.22 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $205.20 | +0.13% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $348.43 | -0.38% | 24.4 | 188.06B |
| GILD | Gilead Sciences Inc | $138.11 | +0.56% | 20.0 | 170.34B |
| VRTX | Vertex Pharmaceuticals Inc | $448.62 | -0.58% | 29.2 | 115.53B |
| REGN | Regeneron Pharmaceuticals | $741.69 | +0.70% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $308.05 | +0.45% | 139.7 | 43.84B |